Subset of esophageal adenocarcinoma expresses adhesion molecule LI in contrast to squamous cell carcinoma

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1195-1200

  Rawnaq, Tamina ^a   Kleinhans, Helge ^a   Marius, Uto ^a   Schurr, Paulus G ^a   Reichelt, Uta ^a   Cataldegirmen, Guellue ^a   Gawad, Karim A ^a   Yekebas, Emre F ^a   Schachner, Melitta ^a   Izbicki, Jakob R ^a   Kaifi, Jussuf T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Esophageal adenocarcinoma; L1 cell adhesion molecule; Therapy target; Tumor marker

Indexed keywords

CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULE L1; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 64949096113     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pohl H and Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Nad Cancer Inst 97: 142-146, 2005.
2. Wei JT and Shaheen N: The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 14: 112-127, 2003
3. Moos M, Tacke R, Scherer H, Teplow D, Fruh K and Schachner M: Neural adhesion molecule LI as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334: 701-703, 1988.
4. Maness PF and Schachner M: Neural recognition molecules of the immunoglobulin superfamily: signalling transducers of axon guidance and neuronal migration. Nat Neurosci 10: 19-36, 2007.
5. De Angelis E, MacFarlane J, Du JS, Yeo G, Hicks R, Rathjen FG, Kenwrick S and Brummendorf T: Pathological missense mutations of neural cell adhesion molecule LI affect homophilic and heterophilic binding activities. EMBO J 18: 4744-4753,1999.
6. Oleszewski M, Beer S, Katich S, Geiger C, Zeller Y, Rauch U and Altevogt P: Integrin and neurocan binding to LI involves distinct Ig domains. J Biol Chem 274: 24602-24610, 1999.
7. Thor G, Probstmeier R and Schachner M: Characterization of the cell adhesion molecules LI, N-CAM and Jl in the mouse intestine. EMBO J 6: 2581-2586, 1987.
8. Probstmeier R, Martini R, Tacke R and Schachner M: Expression of the adhesion molecules LI, N-CAM and Jl/tenascin during development of the murine small intestine. Differentiation 44: 42-55, 1990.
9. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, Strate T, Schneider C, Pantel K, Schachner M, Sauter G and Izbicki JR: LI is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20: 1183-1190,2007.
10. Miyahara R, Tanaka F, Nakagawa T, Matsuoka K, Isii K and Wada H: Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and Ll-cell adhesion molecule) on resected small cell lung cancer specimens: in relation to proliferation state. J Surg Oncol 77: 49-54, 2001.
11. Gil OD, Sakurai T, Bradley AE, Fink MY, Cassella MR, Kuo JA and Felsenfeld DP: Ankyrin binding mediates L1CAM interactions with static components of the cytoskeleton and inhibits retrograde movement of L1CAM on the cell surface. J Cell Biol 162: 719-730, 2003.
12. Linnemann D, Raz A and Bock E: Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer 43: 709-712, 1989.
13. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G and Schumacher U: Overexpression of the cell adhesion molecule LI is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38: 1708-1716, 2002.
14. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M and Altevogt P: ADAM10- mediated cleavage of LI adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17: 292-294, 2003.
15. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M and Altevogt P: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003.
16. Kaifi JT, Zinnkann U, Yekebas EF, Schurr PG, Reichelt U, Wachowiak R, Fiegel HC, Petri S, Schachner M and Izbicki JR: L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma. World J Gastroenterol 12: 94-98, 2006.
17. Kaifi JT, Heidtmann S, Schurr PG, Reichelt U, Mann O, Yekebas EF, Wachowiak R, Strate T, Schachner M and Izbicki JR: Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas. Anticancer Res 26: 1167-1170, 2006.
18. Ben-Arie A, Huszar M, Ben-Zvi N, Smirnov A, Altevogt P and Fogel M: The role of Ll-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women. Eur J Surg Oncol 34: 795-799, 2007.
19. Kaifi JT, Strelow A, Schurr PG, Reichelt U, Yekebas EF, Wachowiak R, Quaas A, Strate T, Schaefer H, Sauter G, Schachner M and Izbicki JR: LI (CD171) is highly expressed in gastrointestinal stromal tumors. Mod Pathol 19: 399-406, 2006.
20. Kalus I, Schnegelsberg B, Seidah NG, Kleene R and Schachner M: The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1. J Biol Chem 278: 10381-10388, 2003.
21. Gutwein P, Oleszewski M, Mechtersheimer S, Agmon-Levin N, Krauss K and Altevogt P: Role of Src kinases in the ADAM- mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem 275: 15490-15497, 2000.
22. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5: 1966-1975, 1999.
23. Ohnishi T, Matsumura H, Izumoto S, Hiraga S and Hayakawa T: A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58: 2935-2940, 1998.
24. Schachner M: Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 9: 627-634, 1997.
25. Kowitz A, Kadmon G, Verschueren H, Remels L, De Baetselier P, Hubbe M, Schachner M, Schirrmacher V and Altevogt P: Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis. Clin Exp Metastasis 11: 419- 429,1993.
26. Fogel M, Mechtersheimer S, Huszar M, Smirnov A, Abu-Dahi A, Tilgen W, Reichrath J, Georg T, Altevogt P and Gutwein P: L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett 189: 237-247, 2003.
27. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 11: 1190-1197, 2005.
28. Wachowiak R, Fiegel HC, Kaifi JT, Quaas A, Krickhahn A, Schurr PG, Erttmann R, Schachner M, Kluth D, Sauter G and Izbicki JR: L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors. Ann Surg Oncol 14: 3575-3580, 2007.
29. Reichelt U, Duesedau P, Tsourlakis M, Quaas A, Link BC, Schurr PG, Kaifi JT, Gros SJ, Yekebas EF, Marx A, Simon R, Izbicki JR and Sauter G: Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol 20: 120-129, 2007.